MedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology

MedTrace Expands Patent Portfolio and Protects Its 15O-Water Technology The U.S. Patent and Trademark Office has confirmed that MedTrace’s way of producing and dosing small volumes of 15O-water with high precision to patients before a PET scan is unique, consequently granting MedTrace a patent. The new patent is a testament to the company’s impressive innovation […]

MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting

MedTrace Pharma’s Novel 15O-Water Technology Showcased at the SNMMI 2023 Annual Meeting MedTrace Pharma is proud to participate with a clinical booth and share the latest about its ongoing Phase 3 Clinical Trial RAPID-WATER-FLOW at this year’s Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2023 annual conference. The company announced recently that the first […]

MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices

MedTrace Earns ISO 13485 Certification, Meeting Stringent Standards for Medical Devices MedTrace is now ISO 13485 certified for the company’s quality management system in medical devices. The first technical file for the medical devices Patient Kit and Patient Kit Extended has been submitted as class IIa products and is currently under review for CE marking. […]

First U.S. Patient Scanned in MedTrace’s 15O-water Phase 3 Trial

First U.S. Patient Scanned in MedTrace’s 15O-Water Phase 3 Trial The first U.S. patient in MedTrace’s phase 3 clinical trial has been dosed and scanned using the company’s automated manufacturing system for producing and dosing 15O-water. The trial seeks to evaluate the use of 15O-water PET in diagnosing coronary artery disease (CAD). It is the first phase […]

Aarhus University Hospital Documents Frequent Extracardiac Findings on 15O-Water PET Myocardial Perfusion Imaging

Aarhus University Hospital document frequent extracardiac findings on 15O-water PET myocardial perfusion imaging From tumors and lung cancer to rib fractures and COVID-19 infiltrates. Researchers at Aarhus University Hospital document that 15O-water PET myocardial perfusion imaging (MPI) often reveals several extracardiac findings or, in other words, findings outside of the intended scope. In their article […]

First Oncology Patient Scanned with 15O-Water on MedTrace Equipment

First Oncology Patient Scanned with 15O-Water on MedTrace Equipment Osaka University Hospital has dosed and scanned the first subject with 15O-water in the university’s scientific study “Evaluation of blood flow of malignant tumor using 15O-water PET”. The study utilized 15O-water from MedTrace’s automated manufacturing system (P3 MT-100). “We are very proud that we have scanned […]

MedTrace Receives U.S. Patent for Diagnosing the Human Heart

MedTrace Receives U.S. Patent for Diagnosing the Human Heart The U.S. Patent and Trademark Office issued a patent to MedTrace for their method of diagnosing the human heart via 15O-water PET. The patented method is the foundation of the company’s software aQuant, currently under development. Hendrik “Hans” Harms, PhD and Senior Scientist at MedTrace, and Jens […]

15O-Water Myocardial Perfusion Imaging: A Practical Approach to Simplifying the Gold Standard for Approved Clinical Use

15O-water myocardial perfusion imaging: a practical approach to simplifying the gold standard for approved clinical use Mark Lubberink, PhD, Scientific Advisor to MedTrace & Hendrik “Hans” Harms, PhD, Senior Scientist at MedTrace, are contributing to the November issue of Society of Nuclear Medicine and Molecular Imaging (SNMMI)’s Value Initiative Newsletter. Lubberink & Harms elaborate on the challenges of […]